Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Acepodia Biotech, Inc.
Fate Therapeutics
Fate Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins